🔗 Permalink

Inventor profile of:

Thomas Quertermous

City:

Stanford, California

Country:

United States

Published Applications:

Last publication date:

2009-12-10

Top Assignees for applications by Thomas Quertermous

The entities that hold a legal rights for patent applications filed by inventor Quertermous Thomas:

The Board of Trustees of the Leland Stanford Junior University 2 Palo Alto, CA United States
VIA Pharmaceuticals, Inc. 1 San Francisco, CA United States
Board of Trustees of the Leland Stanford Junior University 1 Palo Alto, CA United States

Recent patent applications by Quertermous Thomas

Thomas Quertermous from Stanford, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2009-12-10

US20090305903A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR DIAGNOSIS, MONITORING AND DEVELOPMENT OF THERAPEUTICS FOR TREATMENT OF ATHEROSCLEROTIC DISEASE

#2 | 2008-09-11

US20080221225A1

Chemistry; metallurgy

Genes associated with restenosis

#3 | 2008-07-31

US20080182779A1

Physics

Apelin and uses thereof

#4 | 2008-02-07

US20080033034A1

Chemistry; metallurgy

Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque

#5 | 2007-11-01

US20070253901A1

Physics

Atherosclerosis genes and related reagents and methods of use thereof

#6 | 2007-10-25

US20070248641A1

Human necessities

Use of Del-1 in hair, bone and cartilage regeneration

#7 | 2007-05-03

US20070099239A1

Physics

Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease

#8 | 2007-04-26

US20070092886A1

Chemistry; metallurgy

Methods and compositions for diagnosis, monitoring and development of therapeutics for treatment of atherosclerotic disease

#9 | 2006-05-04

US20060094038A1

Physics

Cardiac pressure overload associated genes

#10 | 2005-09-22

US20050207974A1

Chemistry; metallurgy

Endothelial cell markers and related reagents and methods of use thereof

#11 | 2005-07-14

US20050152836A1

Physics

Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof

InventorID:

4071386 ⎘